Page 62 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine The novel index and osteoradionecrosis

all participants provided written informed consent for Maxillofac Surg. 1987;45:104-110.
collecting and publishing associated outcomes, as required doi: 10.1016/0278-2391(87)90399-5
by our institution’s policies and procedures.
8. Cheng VS, Wang CC. Osteoradionecrosis of the mandible
Consent for publication resulting from external megavoltage radiation therapy.
Radiology. 1974;112:685-689.
We ensured that all patients signed an informed consent doi: 10.1148/112.3.685
form before the beginning of the evaluation, either
themselves or their legally authorized representatives for 9. Rankow RM, Weissman B. Osteoradionecrosis of the
acquisition and analysis of the patient’s sociodemographic, mandible. Ann Otol Rhinol Laryngol. 1971;80:603-611.
dental, and medical records; blood samples, and publication doi: 10.1177/000348947108000426
of the outcomes. 10. Reuther T, Schuster T, Mende U, KüblerA. Osteoradionecrosis
Availability of data of the jaws as a side effect of radiotherapy of head and neck
tumour patients--a report of a thirty year retrospective
Data cannot be shared publicly because it is owned review. Int J Oral Maxillofac Surg. 2003;32:289-295.
and saved by the Baskent University Medical Faculty. doi: 10.1054/ijom.2002.0332
However, for researchers who meet the criteria for access 11. Kluth EV, Jain PR, Stuchell RN, Frich JC Jr. A study of factors
to confidential data, data are available from the Baskent contributing to the development of osteoradionecrosis of
University Institutional Data Access/Ethics Committee the jaws. J Prosthet Dent. 1988;59:194-201.
(contact through Baskent University Ethics Committee):
contact address, adanabaskent@baskent.edu.tr. doi: 10.1016/0022-3913(88)90015-7
12. Morrish RB Jr., Chan E, Silverman S Jr., Meyer J, Fu KK,
References Greenspan D. Osteonecrosis in patients irradiated for head
and neck carcinoma. Cancer. 1981;47:1980-1983.
1. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J.
Nasopharyngeal carcinoma. Lancet. 2019;394:64-80. doi: 10.1002/1097-0142(19810415)47:8<1980:aid-
doi: 10.1016/S0140-6736(19)30956-0 cncr2820470813>3.0.co;2-y
2. Su L, She L, Shen L. The current role of adjuvant chemotherapy 13. Marx RE. Osteoradionecrosis: A new concept of its
in locally advanced nasopharyngeal carcinoma. Front Oncol. pathophysiology. J Oral Maxillofac Surg. 1983;41:283-288.
2022;10:585046. doi: 10.1016/0278-2391(83)90294-x
doi: 10.3389/fonc.2020.585046 14. Garg H, Ramaraj PN, Palekar MG, Jain V. Changing trend in
3. De Felice F, Musio D, Terenzi V, et al. Treatment improvement management of Osteoradionecrosis of the mandible: A case
and better patient care: Which is the most important one in report. Int J Appl Dent Sci. 2018;4:271-274.
oral cavity cancer? Radiat Oncol. 2014;9:263. 15. Guven DC, Sahin TK, Erul E, Kilickap S, Gambichler T,
doi: 10.1186/s13014-014-0263-x Aksoy S. The Association between the pan-immune-
inflammation value and cancer prognosis: A Systematic
4. De Felice F, de Vincentiis M, Luzzi V, et al. Late radiation- review and meta-analysis. Cancers. 2022;14:2675.
associated dysphagia in head and neck cancer patients:
Evidence, research and management. Oral Oncol. doi: 10.3390/cancers14112675
2018;77:125-130. 16. Saund DS, Pearson D, Dietrich T. Reliability and validity of
self-assessment of mouth opening: A validation study. BMC
doi: 10.1016/j.oraloncology.2017.12.021
Oral Health. 2012;12:48.
5. Pignon JP, le Maître A, Maillard E, MACH-NC Collaborative
Group. Meta-analysis of chemotherapy in head and neck doi: 10.1186/1472-6831-12-48
cancer (MACH-NC): An update on 93 randomised trials 17. Lee LE, Ahn SS, Pyo JY, Song JJ, Park YB, Lee SW. Pan-
and 17,346 patients. Radiother Oncol. 2009;92:4-14. immune-inflammation value at diagnosis independently
predicts all-cause mortality in patients with antineutrophil
doi: 10.1016/j.radonc.2009.04.014
cytoplasmic antibody-associated vasculitis. Clin Exp
6. Meleca JB, Zhang E, Fritz MA, Ciolek PJ. Overview and Rheumatol. 2021;129:88-93.
emerging trends in the treatment of osteoradionecrosis. doi: 10.55563/clinexprheumatol/m46d0v
Curr Treat Options Oncol. 2021;22:115.
18. Corti F, Lonardi S, Intini R, et al. The pan-immune-
doi: 10.1007/s11864-021-00915-3
inflammation value in microsatellite instability-high
7. Epstein JB, Wong FL, Stevenson-Moore P. Osteoradionecrosis: metastatic colorectal cancer patients treated with immune
Clinical experience and a proposal for classification. J Oral checkpoint inhibitors. Eur J Cancer. 2021;150:155-167.

Volume 3 Issue 1 (2025) 54 doi: 10.36922/arnm.5799